Filtros : "FERRAZ, HUMBERTO GOMES" Limpar

Filtros



Refine with date range


  • Source: Pharmaceutics. Unidade: FCF

    Assunto: PLANEJAMENTO DE FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LEON, Rosmery Merma et al. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet. Pharmaceutics, v. 15, p. 1-20 art. 1735, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15061735. Acesso em: 17 jul. 2024.
    • APA

      Leon, R. M., Issa, M. G., Duque, M. D., Daniel, J. S. P., & Ferraz, H. G. (2023). Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet. Pharmaceutics, 15, 1-20 art. 1735. doi:10.3390/pharmaceutics15061735
    • NLM

      Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet [Internet]. Pharmaceutics. 2023 ; 15 1-20 art. 1735.[citado 2024 jul. 17 ] Available from: https://doi.org/10.3390/pharmaceutics15061735
    • Vancouver

      Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet [Internet]. Pharmaceutics. 2023 ; 15 1-20 art. 1735.[citado 2024 jul. 17 ] Available from: https://doi.org/10.3390/pharmaceutics15061735
  • Source: International Journal of Biological Macromolecules. Unidades: EACH, FCF, FOB

    Assunto: BIOMATERIAIS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PINTO, Marília Martins Rodrigues et al. Agarose fibers with glycerol and graphene oxide and functional properties for potential application in biomaterials. International Journal of Biological Macromolecules, v. 253, p. 01-12, 2023Tradução . . Disponível em: http://dx.doi.org/10.1016/j.ijbiomac.2023.127204. Acesso em: 17 jul. 2024.
    • APA

      Pinto, M. M. R., Sánchez, A. A. C., Costa, S. M. da, Nascimento, J. H. O. do, Galvão, F., Lima, F. S. de, et al. (2023). Agarose fibers with glycerol and graphene oxide and functional properties for potential application in biomaterials. International Journal of Biological Macromolecules, 253, 01-12. doi:10.1016/j.ijbiomac.2023.127204
    • NLM

      Pinto MMR, Sánchez AAC, Costa SM da, Nascimento JHO do, Galvão F, Lima FS de, Ferraz HG, Oliveira RC de, Costa SA da. Agarose fibers with glycerol and graphene oxide and functional properties for potential application in biomaterials [Internet]. International Journal of Biological Macromolecules. 2023 ; 253 01-12.[citado 2024 jul. 17 ] Available from: http://dx.doi.org/10.1016/j.ijbiomac.2023.127204
    • Vancouver

      Pinto MMR, Sánchez AAC, Costa SM da, Nascimento JHO do, Galvão F, Lima FS de, Ferraz HG, Oliveira RC de, Costa SA da. Agarose fibers with glycerol and graphene oxide and functional properties for potential application in biomaterials [Internet]. International Journal of Biological Macromolecules. 2023 ; 253 01-12.[citado 2024 jul. 17 ] Available from: http://dx.doi.org/10.1016/j.ijbiomac.2023.127204
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: ÓLEOS ESSENCIAIS, COMPOSTOS VOLÁTEIS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BELEM, Bruna Rodrigues et al. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene. Pharmaceutics, v. 15, p. 1-23 art. 2564, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112564. Acesso em: 17 jul. 2024.
    • APA

      Belem, B. R., Carapeto, G. V., Issa, M. G., & Ferraz, H. G. (2023). Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene. Pharmaceutics, 15, 1-23 art. 2564. doi:10.3390/pharmaceutics15112564
    • NLM

      Belem BR, Carapeto GV, Issa MG, Ferraz HG. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene [Internet]. Pharmaceutics. 2023 ; 15 1-23 art. 2564.[citado 2024 jul. 17 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112564
    • Vancouver

      Belem BR, Carapeto GV, Issa MG, Ferraz HG. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene [Internet]. Pharmaceutics. 2023 ; 15 1-23 art. 2564.[citado 2024 jul. 17 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112564
  • Source: Resumos. Conference titles: Simpósio Internacional de Iniciação Científica e Tecnológica da USP/SIICUSP. Unidade: FCF

    Subjects: FARMACOTÉCNICA, COMPRIMIDOS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BERNARDINI, Letícia Quarti et al. Utilização de meios biorrelevantes para a avaliação da dissolução de comprimidos de alopurinol. 2023, Anais.. São Paulo: Pró-Reitoria de Pesquisa da USP, 2023. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 17 jul. 2024.
    • APA

      Bernardini, L. Q., Cavichon, E. G., Ferraz, H. G., & Issa, M. G. (2023). Utilização de meios biorrelevantes para a avaliação da dissolução de comprimidos de alopurinol. In Resumos. São Paulo: Pró-Reitoria de Pesquisa da USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
    • NLM

      Bernardini LQ, Cavichon EG, Ferraz HG, Issa MG. Utilização de meios biorrelevantes para a avaliação da dissolução de comprimidos de alopurinol [Internet]. Resumos. 2023 ;[citado 2024 jul. 17 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
    • Vancouver

      Bernardini LQ, Cavichon EG, Ferraz HG, Issa MG. Utilização de meios biorrelevantes para a avaliação da dissolução de comprimidos de alopurinol [Internet]. Resumos. 2023 ;[citado 2024 jul. 17 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
  • Source: Process Biochemistry. Unidades: EACH, FCF

    Assunto: QUITOSANA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CERÓN, Annie A. et al. Study of stability, kinetic parameters and release of lysozyme immobilized on chitosan microspheres by crosslinking and covalent attachment for cotton fabric functionalization. Process Biochemistry, v. 128, p. 116-125, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.procbio.2023.02.023. Acesso em: 17 jul. 2024.
    • APA

      Cerón, A. A., Costa, S. A. da, Imbernon, R. A. L., Queiroz, R. de, Castro, J. de, Ferraz, H. G., et al. (2023). Study of stability, kinetic parameters and release of lysozyme immobilized on chitosan microspheres by crosslinking and covalent attachment for cotton fabric functionalization. Process Biochemistry, 128, 116-125. doi:10.1016/j.procbio.2023.02.023
    • NLM

      Cerón AA, Costa SA da, Imbernon RAL, Queiroz R de, Castro J de, Ferraz HG, Oliveira R, Costa SM da. Study of stability, kinetic parameters and release of lysozyme immobilized on chitosan microspheres by crosslinking and covalent attachment for cotton fabric functionalization [Internet]. Process Biochemistry. 2023 ; 128 116-125.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.procbio.2023.02.023
    • Vancouver

      Cerón AA, Costa SA da, Imbernon RAL, Queiroz R de, Castro J de, Ferraz HG, Oliveira R, Costa SM da. Study of stability, kinetic parameters and release of lysozyme immobilized on chitosan microspheres by crosslinking and covalent attachment for cotton fabric functionalization [Internet]. Process Biochemistry. 2023 ; 128 116-125.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.procbio.2023.02.023
  • Source: Journal of the Korean Ceramic Society. Unidade: FCF

    Subjects: IMPRESSÃO 3-D, TERMOANÁLISE, FOSFATOS, CÁLCIO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOPERA, Alex A et al. Obtaining a fused PLA-calcium phosphate-tobramycin-based filament for 3D printing with potential antimicrobial application. Journal of the Korean Ceramic Society, v. 60, n. 1, p. 169-182, 2023Tradução . . Disponível em: https://doi.org/10.1007/s43207-022-00255-4. Acesso em: 17 jul. 2024.
    • APA

      Lopera, A. A., Bezzon, V. D. N., Ospina, V., Castro, J. L. H., Ramirez, F. J., Ferraz, H. G., et al. (2023). Obtaining a fused PLA-calcium phosphate-tobramycin-based filament for 3D printing with potential antimicrobial application. Journal of the Korean Ceramic Society, 60( 1), 169-182. doi:10.1007/s43207-022-00255-4
    • NLM

      Lopera AA, Bezzon VDN, Ospina V, Castro JLH, Ramirez FJ, Ferraz HG, Orlando MTA, Paucar CG, Robledo SM, Garcia CP. Obtaining a fused PLA-calcium phosphate-tobramycin-based filament for 3D printing with potential antimicrobial application [Internet]. Journal of the Korean Ceramic Society. 2023 ; 60( 1): 169-182.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1007/s43207-022-00255-4
    • Vancouver

      Lopera AA, Bezzon VDN, Ospina V, Castro JLH, Ramirez FJ, Ferraz HG, Orlando MTA, Paucar CG, Robledo SM, Garcia CP. Obtaining a fused PLA-calcium phosphate-tobramycin-based filament for 3D printing with potential antimicrobial application [Internet]. Journal of the Korean Ceramic Society. 2023 ; 60( 1): 169-182.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1007/s43207-022-00255-4
  • Source: Nanomedicine. Unidade: FCF

    Subjects: DOENÇA PULMONAR OBSTRUTIVA CRÔNICA, NANOPARTÍCULAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BHAT, Asif Ahmad et al. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling. Nanomedicine, v. 18, n. 7, p. 583-587, 2023Tradução . . Disponível em: https://doi.org/10.2217/nnm-2023-0032. Acesso em: 17 jul. 2024.
    • APA

      Bhat, A. A., Gilhotra, R., Singh, Y., Sharma, S., Pinto, T. de J. A., Ferraz, H. G., et al. (2023). Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling. Nanomedicine, 18( 7), 583-587. doi:10.2217/nnm-2023-0032
    • NLM

      Bhat AA, Gilhotra R, Singh Y, Sharma S, Pinto T de JA, Ferraz HG, Singh SK, Dua K, Gupta G. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling [Internet]. Nanomedicine. 2023 ; 18( 7): 583-587.[citado 2024 jul. 17 ] Available from: https://doi.org/10.2217/nnm-2023-0032
    • Vancouver

      Bhat AA, Gilhotra R, Singh Y, Sharma S, Pinto T de JA, Ferraz HG, Singh SK, Dua K, Gupta G. Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling [Internet]. Nanomedicine. 2023 ; 18( 7): 583-587.[citado 2024 jul. 17 ] Available from: https://doi.org/10.2217/nnm-2023-0032
  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: CÁLCIO, OSTEOPOROSE, SUPLEMENTOS DIETÉTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Rosana Pereira da et al. Dissolution profile of calcium supplements in Brazil: a critical analysis and formulation proposal. Dissolution Technologies, v. 30, n. 3, p. 154-161, 2023Tradução . . Disponível em: https://doi.org/10.14227/DT300323P154. Acesso em: 17 jul. 2024.
    • APA

      Silva, R. P. da, Issa, M. G., Bezzon, V. D. N., Rodrigues, A. G., & Ferraz, H. G. (2023). Dissolution profile of calcium supplements in Brazil: a critical analysis and formulation proposal. Dissolution Technologies, 30( 3), 154-161. doi:10.14227/DT300323P154
    • NLM

      Silva RP da, Issa MG, Bezzon VDN, Rodrigues AG, Ferraz HG. Dissolution profile of calcium supplements in Brazil: a critical analysis and formulation proposal [Internet]. Dissolution Technologies. 2023 ; 30( 3): 154-161.[citado 2024 jul. 17 ] Available from: https://doi.org/10.14227/DT300323P154
    • Vancouver

      Silva RP da, Issa MG, Bezzon VDN, Rodrigues AG, Ferraz HG. Dissolution profile of calcium supplements in Brazil: a critical analysis and formulation proposal [Internet]. Dissolution Technologies. 2023 ; 30( 3): 154-161.[citado 2024 jul. 17 ] Available from: https://doi.org/10.14227/DT300323P154
  • Source: Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: MEDICAMENTO, BIOEQUIVALÊNCIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANTOS, Everton Miranda dos et al. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space. Journal of Pharmaceutical Sciences, v. 112, n. 12, p. 3131-3140, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2023.07.012. Acesso em: 17 jul. 2024.
    • APA

      Santos, E. M. dos, Ferraz, H. G., Issa, M. G., & Duque, M. D. (2023). Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space. Journal of Pharmaceutical Sciences, 112( 12), 3131-3140. doi:10.1016/j.xphs.2023.07.012
    • NLM

      Santos EM dos, Ferraz HG, Issa MG, Duque MD. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space [Internet]. Journal of Pharmaceutical Sciences. 2023 ; 112( 12): 3131-3140.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.xphs.2023.07.012
    • Vancouver

      Santos EM dos, Ferraz HG, Issa MG, Duque MD. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space [Internet]. Journal of Pharmaceutical Sciences. 2023 ; 112( 12): 3131-3140.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.xphs.2023.07.012
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: MEDICAMENTO GENÉRICO, BIOEQUIVALÊNCIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARAPETO, Gustavo Vaiano et al. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets. Pharmaceutics, v. 15, p. 1-14 art. 1544, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15051544. Acesso em: 17 jul. 2024.
    • APA

      Carapeto, G. V., Duque, M. D., Issa, M. G., & Ferraz, H. G. (2023). Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets. Pharmaceutics, 15, 1-14 art. 1544. doi:10.3390/pharmaceutics15051544
    • NLM

      Carapeto GV, Duque MD, Issa MG, Ferraz HG. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets [Internet]. Pharmaceutics. 2023 ; 15 1-14 art. 1544.[citado 2024 jul. 17 ] Available from: https://doi.org/10.3390/pharmaceutics15051544
    • Vancouver

      Carapeto GV, Duque MD, Issa MG, Ferraz HG. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets [Internet]. Pharmaceutics. 2023 ; 15 1-14 art. 1544.[citado 2024 jul. 17 ] Available from: https://doi.org/10.3390/pharmaceutics15051544
  • Source: Powder Technology. Unidade: FCF

    Subjects: CARBONATOS, CÁLCIO, OSTEOPOROSE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Rosana Pereira da et al. Wet powder rheometry: the best conditions for wet granulation using diluent and binder in calcium carbonate samples. Powder Technology, v. 397, n. 2, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.powtec.2021.117087. Acesso em: 17 jul. 2024.
    • APA

      Silva, R. P. da, Fante, A. S., Silva, A. R. P., Pereira, F. L. S., Gutierrez, Y. L. R., & Ferraz, H. G. (2022). Wet powder rheometry: the best conditions for wet granulation using diluent and binder in calcium carbonate samples. Powder Technology, 397( 2), 1-11. doi:10.1016/j.powtec.2021.117087
    • NLM

      Silva RP da, Fante AS, Silva ARP, Pereira FLS, Gutierrez YLR, Ferraz HG. Wet powder rheometry: the best conditions for wet granulation using diluent and binder in calcium carbonate samples [Internet]. Powder Technology. 2022 ; 397( 2): 1-11.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.powtec.2021.117087
    • Vancouver

      Silva RP da, Fante AS, Silva ARP, Pereira FLS, Gutierrez YLR, Ferraz HG. Wet powder rheometry: the best conditions for wet granulation using diluent and binder in calcium carbonate samples [Internet]. Powder Technology. 2022 ; 397( 2): 1-11.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.powtec.2021.117087
  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: TRATO GASTROINTESTINAL, FARMACOCINÉTICA, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Daniela Amaral et al. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, v. 29, n. 2, p. 62-75, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P62. Acesso em: 17 jul. 2024.
    • APA

      Silva, D. A., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2022). Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, 29( 2), 62-75. doi:10.14227/DT290222P62
    • NLM

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 jul. 17 ] Available from: https://doi.org/10.14227/DT290222P62
    • Vancouver

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 jul. 17 ] Available from: https://doi.org/10.14227/DT290222P62
  • Source: Journal of Pharmacy and Pharmacognosy Research. Unidade: FCF

    Subjects: ESPECTROFOTOMETRIA, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CHAUCA, Enma Perez e PLASENCIA, Pedro M. Alva e FERRAZ, Humberto Gomes. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test. Journal of Pharmacy and Pharmacognosy Research, v. 10, n. 5, p. 847-856, 2022Tradução . . Disponível em: https://doi.org/10.56499/jppres22.1433_10.5.847. Acesso em: 17 jul. 2024.
    • APA

      Chauca, E. P., Plasencia, P. M. A., & Ferraz, H. G. (2022). Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test. Journal of Pharmacy and Pharmacognosy Research, 10( 5), 847-856. doi:10.56499/jppres22.1433_10.5.847
    • NLM

      Chauca EP, Plasencia PMA, Ferraz HG. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2022 ; 10( 5): 847-856.[citado 2024 jul. 17 ] Available from: https://doi.org/10.56499/jppres22.1433_10.5.847
    • Vancouver

      Chauca EP, Plasencia PMA, Ferraz HG. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2022 ; 10( 5): 847-856.[citado 2024 jul. 17 ] Available from: https://doi.org/10.56499/jppres22.1433_10.5.847
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: INDÚSTRIA FARMACÊUTICA, MEDICAMENTO, BIOEQUIVALÊNCIA, FORMAS FARMACÊUTICAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ISSA, Michele Georges et al. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling. Pharmaceutics, v. 14, p. 1-21 art. 892, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14050892. Acesso em: 17 jul. 2024.
    • APA

      Issa, M. G., Souza, N. V. de, Jou, B. W. C., Duque, M. D., & Ferraz, H. G. (2022). Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling. Pharmaceutics, 14, 1-21 art. 892. doi:10.3390/pharmaceutics14050892
    • NLM

      Issa MG, Souza NV de, Jou BWC, Duque MD, Ferraz HG. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 892.[citado 2024 jul. 17 ] Available from: https://doi.org/10.3390/pharmaceutics14050892
    • Vancouver

      Issa MG, Souza NV de, Jou BWC, Duque MD, Ferraz HG. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 892.[citado 2024 jul. 17 ] Available from: https://doi.org/10.3390/pharmaceutics14050892
  • Source: Revista Peruana de Medicina Experimental y Salud Pública. Unidade: FCF

    Subjects: MEDICAMENTO GENÉRICO, BIOEQUIVALÊNCIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CHAUCA, Enma Perez e FERRAZ, Humberto Gomes. Interchangeability of drugs in Peru: Current outlook and future perspectives. Revista Peruana de Medicina Experimental y Salud Pública, v. 38, n. 2, p. 337-344, 2021Tradução . . Disponível em: https://doi.org/10.17843/rpmesp.2021.382.7322. Acesso em: 17 jul. 2024.
    • APA

      Chauca, E. P., & Ferraz, H. G. (2021). Interchangeability of drugs in Peru: Current outlook and future perspectives. Revista Peruana de Medicina Experimental y Salud Pública, 38( 2), 337-344. doi:10.17843/rpmesp.2021.382.7322
    • NLM

      Chauca EP, Ferraz HG. Interchangeability of drugs in Peru: Current outlook and future perspectives [Internet]. Revista Peruana de Medicina Experimental y Salud Pública. 2021 ; 38( 2): 337-344.[citado 2024 jul. 17 ] Available from: https://doi.org/10.17843/rpmesp.2021.382.7322
    • Vancouver

      Chauca EP, Ferraz HG. Interchangeability of drugs in Peru: Current outlook and future perspectives [Internet]. Revista Peruana de Medicina Experimental y Salud Pública. 2021 ; 38( 2): 337-344.[citado 2024 jul. 17 ] Available from: https://doi.org/10.17843/rpmesp.2021.382.7322
  • Source: Dissolution Technology. Unidade: FCF

    Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Daniela Amaral et al. A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, v. 28, n. 4, p. 40-48, 2021Tradução . . Disponível em: https://doi.org/10.14227/DT280421P40. Acesso em: 17 jul. 2024.
    • APA

      Silva, D. A., Melo, K. J. C., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2021). A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, 28( 4), 40-48. doi:10.14227/DT280421P40
    • NLM

      Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 jul. 17 ] Available from: https://doi.org/10.14227/DT280421P40
    • Vancouver

      Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 jul. 17 ] Available from: https://doi.org/10.14227/DT280421P40
  • Source: Journal of Supercritical Fluids. Unidades: FCF, IQ

    Subjects: ANTI-INFLAMATÓRIOS, DIÓXIDO DE CARBONO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OBI, Lígia Passos Maia et al. Non-inclusion complexation of peracetylated β-Cyclodextrin with ibuprofen in supercritical carbon dioxide. Journal of Supercritical Fluids, v. 169, p. 1-9 art. 105098, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.supflu.2020.105098. Acesso em: 17 jul. 2024.
    • APA

      Obi, L. P. M., Vidinha, P., Ferraz, H. G., & Bazito, R. C. (2021). Non-inclusion complexation of peracetylated β-Cyclodextrin with ibuprofen in supercritical carbon dioxide. Journal of Supercritical Fluids, 169, 1-9 art. 105098. doi:10.1016/j.supflu.2020.105098
    • NLM

      Obi LPM, Vidinha P, Ferraz HG, Bazito RC. Non-inclusion complexation of peracetylated β-Cyclodextrin with ibuprofen in supercritical carbon dioxide [Internet]. Journal of Supercritical Fluids. 2021 ; 169 1-9 art. 105098.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.supflu.2020.105098
    • Vancouver

      Obi LPM, Vidinha P, Ferraz HG, Bazito RC. Non-inclusion complexation of peracetylated β-Cyclodextrin with ibuprofen in supercritical carbon dioxide [Internet]. Journal of Supercritical Fluids. 2021 ; 169 1-9 art. 105098.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1016/j.supflu.2020.105098
  • Source: Solids. Unidades: IGC, FCF

    Subjects: CARBONATOS, CÁLCIO, OLIGOELEMENTOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Rosana Pereira da et al. Characterisation and traceability of calcium carbonate from the seaweed Lithothamnium calcareum. Solids, v. 2, n. 2, p. 192-211, 2021Tradução . . Disponível em: https://doi.org/10.3390/solids2020013. Acesso em: 17 jul. 2024.
    • APA

      Silva, R. P. da, Kawai, G. S. D., Andrade, F. R. D. de, Bezzon, V. D. N., & Ferraz, H. G. (2021). Characterisation and traceability of calcium carbonate from the seaweed Lithothamnium calcareum. Solids, 2( 2), 192-211. doi:10.3390/solids2020013
    • NLM

      Silva RP da, Kawai GSD, Andrade FRD de, Bezzon VDN, Ferraz HG. Characterisation and traceability of calcium carbonate from the seaweed Lithothamnium calcareum [Internet]. Solids. 2021 ; 2( 2): 192-211.[citado 2024 jul. 17 ] Available from: https://doi.org/10.3390/solids2020013
    • Vancouver

      Silva RP da, Kawai GSD, Andrade FRD de, Bezzon VDN, Ferraz HG. Characterisation and traceability of calcium carbonate from the seaweed Lithothamnium calcareum [Internet]. Solids. 2021 ; 2( 2): 192-211.[citado 2024 jul. 17 ] Available from: https://doi.org/10.3390/solids2020013
  • Source: Helou, Cimino, Daffre: Farmacotécnica. Unidade: FCF

    Assunto: AEROSSOL

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GIORGETTI, Leandro e FERRAZ, Humberto Gomes. Aerossóis. Helou, Cimino, Daffre: Farmacotécnica. Tradução . Rio de Janeiro: Atheneu, 2021. . . Acesso em: 17 jul. 2024.
    • APA

      Giorgetti, L., & Ferraz, H. G. (2021). Aerossóis. In Helou, Cimino, Daffre: Farmacotécnica. Rio de Janeiro: Atheneu.
    • NLM

      Giorgetti L, Ferraz HG. Aerossóis. In: Helou, Cimino, Daffre: Farmacotécnica. Rio de Janeiro: Atheneu; 2021. [citado 2024 jul. 17 ]
    • Vancouver

      Giorgetti L, Ferraz HG. Aerossóis. In: Helou, Cimino, Daffre: Farmacotécnica. Rio de Janeiro: Atheneu; 2021. [citado 2024 jul. 17 ]
  • Source: AAPS PharmSciTech. Unidade: FCF

    Subjects: POLIMORFISMO, FARMACOCINÉTICA, SOLUBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      REPIN, Ilia Alekseevich et al. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics. AAPS PharmSciTech, v. 22, p. 1-11 art. 54, 2021Tradução . . Disponível em: https://doi.org/10.1208/s12249-021-01923-0. Acesso em: 17 jul. 2024.
    • APA

      Repin, I. A., Loebenberg, R., DiBella, J., Conceição, A. C. L., Piedade, M. E. M. da, Ferraz, H. G., et al. (2021). Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics. AAPS PharmSciTech, 22, 1-11 art. 54. doi:10.1208/s12249-021-01923-0
    • NLM

      Repin IA, Loebenberg R, DiBella J, Conceição ACL, Piedade MEM da, Ferraz HG, Issa MG, Bou-Chacra NA, Ermida CFM, Araujo GLB de. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics [Internet]. AAPS PharmSciTech. 2021 ; 22 1-11 art. 54.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1208/s12249-021-01923-0
    • Vancouver

      Repin IA, Loebenberg R, DiBella J, Conceição ACL, Piedade MEM da, Ferraz HG, Issa MG, Bou-Chacra NA, Ermida CFM, Araujo GLB de. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics [Internet]. AAPS PharmSciTech. 2021 ; 22 1-11 art. 54.[citado 2024 jul. 17 ] Available from: https://doi.org/10.1208/s12249-021-01923-0

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024